Hodgkin’s Lymphoma
Show Only Open Trials
1.
A phase II study of brentuximab vedotin as salvage therapy for Hodgkin Lymphoma prior to autologous hematopoietic stem cell transplantation
- Study Status: Open to Enrollment
- Sponsor: City of Hope
- Disease Status and/or Stage: Relapsed or Refractory to One Frontline Induction Therapy
2.
A Pilot Study of a Sequential Regimen of Intensive Chemotherapy Followed by Autologous or Allogeneic Transplantation for Refractory Lymphoma (Non-Hodgkin's and Hodgkin's)
- Study Status: Open to Enrollment
- Sponsor: Weill Cornell Medical College
- Disease Status and/or Stage: Refractory Lymphoma (non-Hodgkin and Hodgkin) in Need of Stem Cell Transplant
3.
A Randomized study of Combined Haplo-identical Umbilical Cord Transplantation vs. Double Umbilical Cord Transplantation in Patients with Hematologic Malignancies
- Study Status: Open to Enrollment
- Sponsor: Weill Cornell Medical College
- Disease Status and/or Stage: Hematologic Malignancies in Need of Donor Stem Cell Transplant
4.
A Prospective Study of Optimally Matched-IPA Targeted Haplo-cord Transplantation
- Study Status: Open to Enrollment
- Sponsor: Weill Cornell Medical College
- Disease Status and/or Stage: Hematologic Malignancies in Need of Donor Stem Cell Transplant
5.
BMT CTN 0903 - Allogeneic Hematopoietic Cell Transplant for Hematological Cancers and Myelodysplastic Syndromes in HIV-Infected Individuals
- Study Status: Open to Enrollment
- Sponsor: BMT-CTN
- Disease Status and/or Stage: Hematologic Cancers and Myelosysplastic Syndromes in HIV-Positive People
- Protocol ID: BMT CTN 0903
6.
CALGB 50801: Phase II Trial of Response-Adapted Therapy Based on Positron Emission of Tomography (PET) for Bulky Stage I and Stage II Classical Hodgkin Lymphoma (HL)
- Study Status: Open to Enrollment
- Sponsor: CALGB
- Disease Status and/or Stage: Bulky, Early Stage Hodgkin Lymphoma
7.
CALGB 50604: Phase II Trial of Response-Adapted Chemotherapy Based on Positron Emission Tomography for Non-Bulky Stage I and II Hodgkin Lymphoma
- Study Status: Open to Enrollment
- Sponsor: CALGB
- Disease Status and/or Stage: Hodgkin Lymphoma, Stage IA, IB, IIA or IIB
- Protocol ID: CALGB 50604
8.
An Open-Label, Dose Escalation, Phase 1 Study of MLN9708, A Second-Generation Proteasome Inhibitor, in Adult Patients with Lymphoma
- Study Status: Open to Enrollment
- Sponsor: Millennium
- Disease Status and/or Stage: Relapsed or Refractory Lymphoma (non-Hodgkin and Hodgkin)
9.
Coping with Lymphoma to Enhance Adjustment and Reduce Stress in Survivors (CLEAR Stress)
- Study Status: Open to Enrollment
- Sponsor: Agency for Healthcare Research and Quality; Weill Cornell Medical College
10.
Pilot study of abbreviated chemotherapy based on early positron emission tomography in Hodgkin lymphoma
- Study Status: Open to Enrollment
- Sponsor: Weill Cornell Medical College
- Disease Status and/or Stage: Untreated Hodgkin Lymphoma
